|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
15,080,000 |
Market
Cap: |
26.99(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.43 - $2.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
30,318 |
Total Buy Value |
$0 |
$0 |
$0 |
$70,308 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
496 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Herman James L |
VP and Chief Compliance Office |
|
2023-03-18 |
4 |
D |
$1.92 |
$2,458 |
D/D |
(1,280) |
39,441 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2023-03-18 |
4 |
D |
$1.92 |
$71,434 |
D/D |
(37,205) |
5,716,153 |
|
- |
|
Anthony Todd M. |
Vice Pres Organizational DevOf |
|
2023-03-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,144 |
|
-32% |
|
Bitterman Chris T. |
Vice Pres Sales & MarketingOff |
|
2023-03-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,276 |
|
-32% |
|
Jacobs Joey A |
Director |
|
2023-01-14 |
4 |
D |
$2.75 |
$13,750 |
D/D |
(5,000) |
98,415 |
|
- |
|
Galante Joseph C |
Director |
|
2022-10-31 |
4 |
AB |
$2.54 |
$165 |
D/D |
65 |
54,441 |
|
-13% |
|
Young Caroline |
Director |
|
2022-10-31 |
4 |
AB |
$2.54 |
$51 |
D/D |
20 |
18,788 |
|
-13% |
|
Krogulski Kenneth |
Director |
|
2022-10-31 |
4 |
AB |
$2.54 |
$267 |
D/D |
105 |
199,700 |
|
-13% |
|
Jones James |
Director |
|
2022-10-31 |
4 |
AB |
$2.54 |
$79 |
D/D |
31 |
24,975 |
|
-13% |
|
Galante Joseph C |
Director |
|
2022-10-28 |
4 |
AB |
$2.52 |
$164 |
D/D |
65 |
54,376 |
|
-13% |
|
Young Caroline |
Director |
|
2022-10-28 |
4 |
AB |
$2.52 |
$50 |
D/D |
20 |
18,768 |
|
-13% |
|
Krogulski Kenneth |
Director |
|
2022-10-28 |
4 |
AB |
$2.52 |
$265 |
D/D |
105 |
199,595 |
|
-13% |
|
Jones James |
Director |
|
2022-10-28 |
4 |
AB |
$2.52 |
$78 |
D/D |
31 |
24,944 |
|
-13% |
|
Galante Joseph C |
Director |
|
2022-10-27 |
4 |
AB |
$2.49 |
$162 |
D/D |
65 |
54,311 |
|
-14% |
|
Young Caroline |
Director |
|
2022-10-27 |
4 |
AB |
$2.49 |
$50 |
D/D |
20 |
18,748 |
|
-14% |
|
Krogulski Kenneth |
Director |
|
2022-10-27 |
4 |
AB |
$2.49 |
$261 |
D/D |
105 |
199,490 |
|
-14% |
|
Jones James |
Director |
|
2022-10-27 |
4 |
AB |
$2.49 |
$77 |
D/D |
31 |
24,913 |
|
-14% |
|
Galante Joseph C |
Director |
|
2022-10-26 |
4 |
AB |
$2.42 |
$157 |
D/D |
65 |
54,246 |
|
-9% |
|
Young Caroline |
Director |
|
2022-10-26 |
4 |
AB |
$2.42 |
$48 |
D/D |
20 |
18,728 |
|
-9% |
|
Krogulski Kenneth |
Director |
|
2022-10-26 |
4 |
AB |
$2.42 |
$254 |
D/D |
105 |
199,385 |
|
-9% |
|
Jones James |
Director |
|
2022-10-26 |
4 |
AB |
$2.42 |
$75 |
D/D |
31 |
24,882 |
|
-9% |
|
Galante Joseph C |
Director |
|
2022-10-25 |
4 |
AB |
$2.44 |
$159 |
D/D |
65 |
54,181 |
|
-1% |
|
Young Caroline |
Director |
|
2022-10-25 |
4 |
AB |
$2.44 |
$49 |
D/D |
20 |
18,708 |
|
-1% |
|
Krogulski Kenneth |
Director |
|
2022-10-25 |
4 |
AB |
$2.44 |
$256 |
D/D |
105 |
199,280 |
|
-1% |
|
Jones James |
Director |
|
2022-10-25 |
4 |
AB |
$2.44 |
$76 |
D/D |
31 |
24,851 |
|
-1% |
|
1400 Records found
|
|
Page 1 of 56 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|